Skip to main content
. 2023 Apr 4;23:226. doi: 10.1186/s12888-023-04605-2

Table 3.

Coverage for posttraumatic stress disorder by severity

Coverage Severe n = 504 Mild/ Moderate n = 410 Any severity n = 914 Significance test
Numerator Denominator % (SE) % (SE) % (SE) F (p-value)
Contact coveragea

People with 12-month PTSD

(n = 914)

58.1 (2.9) 32.7 (2.6) 43.0 (2.2) 43.31* (<.001)
Any psychotropic medicationb,c 46.5 (2.7) 23.1 (2.3) 32.7 (1.9) 37.64* (<.001)
Antidepressantsd 34.1 (2.5) 13.8 (1.7) 22.1 (1.6) 47.72* (<.001)
Adequate medication controle 32.1 (2.6) 9.4 (1.5) 18.7 (1.5) 53.48* (<.001)
Adequate pharmacotherapyf 23.0 (2.4) 7.0 (1.3) 13.5 (1.4) 35.74* (<.001)
Any psychotherapyg 29.5 (2.5) 13.3 (1.6) 19.9 (1.5) 31.52* (<.001)
Adequate psychotherapyh 28.0 (2.6) 9.7 (1.5) 17.2 (1.5) 47.56* (<.001)
Effective coveragei 18.5 (2.2) 11.7 (1.7) 14.4 (1.4) 6.03* (0.01)

Abbreviations: PTSD Posttraumatic stress disorder, SE Standard error

*Significant at the .05 level, two-sided test

aContact coverage required any 12-month contact with a specialist or general medical provider for a mental health condition

bRequires any 12-month healthcare/contact coverage too

cAny psychotropic required receiving any psychotropic and any 12-month healthcare

dAntidepressants required appropriate medication (antidepressant) and any 12-month healthcare

eAdequate medication control required at least four physician visits

fAdequate pharmacotherapy required taking an antidepressant with adequate medication control and adherence

gAny psychotherapy required having two or more visits to any specialty mental health provider among help seekers

hAdequate psychotherapy required at least 8 sessions from an adequate provider or still being in treatment after 2 visits

iEffective treatment coverage, for mild and moderate PTSD required adequate pharmacotherapy and/or adequate psychotherapy, and for severe PSTD both adequate pharmacotherapy and adequate psychotherapy